Back

Pregnancy associated hypertensive disorders and risk of cardiovascular disease: a mendelian randomisation study

26 August 2023 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Predicting and managing maternal cardiovascular risk during pregnancy Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Lena Tschiderer

Medical University of Innsbruck, Innsbruck (Austria)

5 More presentations in this session

Presentation thumbnail
Cardiovascular impact on risk of preeclampsia, -an epidemiologic cohort study
Doctor K. Bergman (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Pregnancy and cardiac maternal outcomes in women with inherited cardiomyopathy: interest of the new CARPREG II risk score
Doctor T. Wallet (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.
Associate Professor T. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Effect of successful bariatric surgery on maternal cardiovascular outcomes
Doctor A. Mustafa (New York, US)
Abstract Slides Video
Presentation thumbnail
Pregnancy-related cardiovascular events in marfan syndrome
Doctor P. Poveda Velazquez (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting and managing maternal cardiovascular risk during pregnancy
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 12:00 CET
You may be interested in
thumbnail
Congress Session
Predicting and managing maternal cardiovascular risk during pregnancy
thumbnail
Congress Presentation
Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.
thumbnail
Congress Presentation
Mendelian randomization study of the relevance of blood pressure to vascular mortality among 150,000 participants in the mexico city prospective study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources